• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804225-33
Device Problem Material Separation (1562)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/08/2022
Event Type  malfunction  
Manufacturer Narrative
Date of event - estimated, treatment / therapy start date - estimated.The device was received.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported the 2.25x33mm xience skypoint stent delivery system was used in a procedure and separated.There was no reported adverse patient effect and no reported clinically significant delay in the procedure.No additional information was provided.
 
Event Description
Subsequent to the initial medwatch report, it was noted that the following occurred sometime during this reported procedure: it was reported that the procedure was to treat a lesion in the left anterior descending (lad) artery with heavy calcification.Pre-dilatation was performed with a non-abbott balloon.Then a 2.25 x 33mm xience skypoint stent delivery system (sds) was attempted to be advanced to the target lesion; however the stent failed to cross due to anatomical challenges.Therefore, the sds was removed and resistance was noted during removal due to anatomical challenges.A flared stent strut was observed.There was no adverse patient effect and no clinically significant delay in the procedure.A second dilatation was performed with a non-abbott balloon followed by deployment of another xience skypoint stent to complete the procedure.This was filed under patient identifier cn-(b)(6).No additional information was provided.
 
Manufacturer Narrative
A visual and dimensional inspection was performed on the returned device.The reported material separation was confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation was unable to determine a conclusive cause for the reported material separation.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14197866
MDR Text Key290062776
Report Number2024168-2022-04481
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648233036
UDI-Public08717648233036
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/17/2024
Device Model Number1804225-33
Device Catalogue Number1804225-33
Device Lot Number1011241
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/24/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/04/2022
Initial Date FDA Received04/25/2022
Supplement Dates Manufacturer Received04/26/2022
Supplement Dates FDA Received05/09/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/18/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-